Search

IQVIA Holdings Inc

Fechado

SetorSaúde

258.18 -0.8

Visão Geral

Variação de preço das ações

24h

Atual

Mín

256.98

Máximo

261.75

Indicadores-chave

By Trading Economics

Rendimento

-17M

258M

Vendas

217M

4.4B

P/E

Médio do Setor

33.661

56.254

EPS

2.75

Margem de lucro

5.907

Funcionários

94,000

EBITDA

-18M

790M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+10.05% upside

Dividendos

By Acuity

Próximos Ganhos

27 de out. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

9B

45B

Abertura anterior

258.98

Fecho anterior

258.18

Sentimento de Notícias

By Acuity

50%

50%

87 / 340 Ranking em Healthcare

IQVIA Holdings Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

2 de out. de 2026, 19:45 UTC

IQVIA Holdings Inc shares fell sharply after reaching a morning high, now trading below the 20-day moving average amid broader market weakness.

1 de out. de 2026, 21:10 UTC

IQVIA Holdings Inc is experiencing notable upward movement in after-market trading, rebounding from an earlier dip and reaching a peak gain since Thursday's close.

30 de set. de 2026, 19:25 UTC

News

IQVIA shares are trading higher as UBS analyst Kevin Caliendo resumes coverage with a Buy rating and a price target of $345.00.

29 de set. de 2026, 22:05 UTC

IQVIA Holdings Inc saw a modest increase in after-market trading, continuing its upward trend since Tuesday's close and remaining above its 20-day moving average.

25 de set. de 2026, 20:07 UTC

Correlated Moves

IQVIA Holdings Inc shares are declining, continuing a downward trend amid a generally weak market, despite an initial stronger start on Friday.

24 de set. de 2026, 23:01 UTC

IQVIA Holdings Inc is trading modestly higher in after-market hours, remaining significantly above its 20-day moving average and near the upper end of its one-month range.

23 de set. de 2026, 19:56 UTC

Correlated Moves

IQVIA Holdings Inc shares fell sharply, moving lower after reaching a session high, amid a decline in Charles River Laboratories International Inc.

22 de set. de 2026, 23:01 UTC

IQVIA Holdings Inc is trading modestly higher in after-market hours, continuing its upward movement and remaining about 3.18% above its 20-day moving average.

21 de set. de 2026, 22:01 UTC

Correlated Moves

IQVIA Holdings Inc is declining in after-market trading, shifting from a slight loss to a more significant one since Monday's close.

18 de set. de 2026, 20:07 UTC

Correlated Moves

IQVIA Holdings Inc shares fell as the broader market declined, although the stock remains above its 20-day moving average and near the upper end of its one-month range.

16 de set. de 2026, 19:36 UTC

IQVIA Holdings Inc shares fell, pulling back from earlier gains, and are currently lower since Tuesday's close while remaining above the 20-day moving average.

15 de set. de 2026, 23:01 UTC

IQVIA Holdings Inc. shares are higher in after-market trading, reflecting a broader market uptick amid no specific company news. The stock remains above its 20-day moving average.

14 de set. de 2026, 23:26 UTC

IQVIA Holdings Inc. shares are lower in after-market trading, reflecting broader market dynamics amid concerns over rising crude oil prices and inflation expectations.

11 de set. de 2026, 20:13 UTC

IQVIA Holdings Inc. shares are trading higher in after-market hours, despite no specific news driving the movement. Inflation data has fueled interest rate hike speculation.

10 de set. de 2026, 20:07 UTC

News

IQVIA Holdings priced a $2 billion senior notes offering to redeem debt. The Arizona State Retirement System raised its stake by 5.1%.

9 de set. de 2026, 19:56 UTC

Correlated Moves
News

IQVIA Holdings plans to raise $2 billion through senior notes. Shares are lower amid concerns over leverage and market conditions affecting financial stability.

8 de set. de 2026, 21:01 UTC

IQVIA Holdings Inc. shares are higher in after-market trading, advancing since Tuesday's close and remaining above their 20-day moving average.

4 de set. de 2026, 20:07 UTC

IQVIA Holdings Inc is lower in Friday's session, reflecting broader market trends. The stock remains above its 20-day moving average despite the decline.

3 de set. de 2026, 22:51 UTC

News

IQVIA Holdings launched its Predictive Clinical Development platform, aimed at enhancing clinical trial efficiency, but shares are trading lower in after-market hours.

2 de set. de 2026, 23:51 UTC

IQVIA Holdings Inc shares rose in after-market trading, continuing upward momentum amid a broader macroeconomic backdrop following the ADP payrolls report.

1 de set. de 2026, 19:36 UTC

Correlated Moves
News

IQVIA Holdings is trading lower today, influenced by Repligen Corp's decline and ongoing challenges in the life sciences sector.

31 de ago. de 2026, 23:46 UTC

News

IQVIA Holdings Inc shares are higher in after-market trading, remaining above their 20-day moving average amid sector growth expectations despite ongoing challenges.

28 de ago. de 2026, 19:36 UTC

News

IQVIA Holdings Inc. raised its 2026 guidance after reporting earnings growth, but shares are trading lower during Friday's session.

27 de ago. de 2026, 23:01 UTC

Shares of IQVIA Holdings Inc. are trading higher in after-market hours, remaining above the 20-day moving average and near the upper end of its one-month range.

26 de ago. de 2026, 23:21 UTC

Shares of IQVIA Holdings Inc. are lower in after-market trading, declining from earlier gains despite remaining above their 20-day moving average.

25 de ago. de 2026, 23:12 UTC

IQVIA Holdings Inc shares are lower in after-market trading. The decline occurs despite broader market gains following a drop in crude oil prices.

24 de ago. de 2026, 19:26 UTC

News
Correlated Moves

IQVIA Holdings Inc is trading roughly flat amid broader market dynamics, with Agilent Technologies Inc declining, suggesting potential influence on sentiment.

21 de ago. de 2026, 23:27 UTC

IQVIA Holdings Inc. shares advanced slightly higher in after-market trading, recovering from an earlier dip as traders engage in bargain hunting.

20 de ago. de 2026, 20:02 UTC

IQVIA Holdings Inc is trading higher today, maintaining strength despite broader market pressures. The stock remains above its 20-day moving average.

19 de ago. de 2026, 21:01 UTC

IQVIA Holdings Inc is higher in after-hours trading, advancing since Wednesday's close and trading near the upper end of its one-month range.

Comparação entre Pares

Variação de preço

IQVIA Holdings Inc Previsão

Preço-alvo

By TipRanks

10.05% parte superior

Previsão para 12 meses

Média 286.933 USD  10.05%

Máximo 345 USD

Mínimo 240 USD

Com base em 16 analistas de Wall Street que oferecem metas de preço de 12 meses para IQVIA Holdings Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

16 ratings

15

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

87 / 340 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.